StockData

Research Alliance Corp III (RACC) stock

RACCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.12+0.00 (0.00%)

Close on Nov 17, 2026Market cap $92.08MP/E –Yield –

Research Alliance Corp III cash

Cash and short-term investments held at the end of each period.

Research Alliance Corp III's cash was $183.41K at Sep 30, 2026.

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$183.41K–
Q2 FY2026Jun 30, 2026$832.81K–
Q1 FY2026Mar 31, 2026$280.28K–

More Research Alliance Corp III figures

See a number that looks wrong?